Smiths Group plc, headquartered in London, is a diversified engineering firm with roots dating back to 1851. Over its long history, the company has evolved from a manufacturer of timepieces into a provider of critical components and systems for industries ranging from energy and natural resources to healthcare and security. Smiths Group is publicly traded on the London Stock Exchange and its American depositary receipts trade over-the-counter under the symbol SMGZY.
The company operates through four principal divisions. John Crane supplies mechanical seals, couplings and support systems for rotating equipment used in oil and gas, petrochemical, power generation and pharmaceutical markets. Smiths Detection offers threat detection and screening technologies—such as X-ray scanners, trace detectors and chemical identification devices—to airports, border control agencies and critical infrastructure sites. Smiths Interconnect designs and manufactures high-performance connectivity and microwave components for aerospace, defense and industrial applications. Smiths Medical produces infusion systems, vascular access devices and patient monitoring products for hospitals and pre-hospital care providers.
Smiths Group maintains a global footprint, with manufacturing, research and development, and service facilities in more than 50 countries across Europe, North America, Asia and the Middle East. This extensive network enables localized engineering support and aftermarket services tailored to the needs of multinational customers. Over the years, the company has pursued strategic acquisitions and partnerships to enhance its technological capabilities and expand its reach in high-growth markets.
Under the leadership of Group Chief Executive Andy Reynolds Smith, Smiths Group continues to focus on innovation and operational excellence. The executive team emphasizes sustained investment in R&D, digital technologies and talent development to drive long-term value for customers and shareholders alike.
AI Generated. May Contain Errors.